These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 11604031)

  • 1. Is there a difference between leads and drugs? A historical perspective.
    Oprea TI; Davis AM; Teague SJ; Leeson PD
    J Chem Inf Comput Sci; 2001; 41(5):1308-15. PubMed ID: 11604031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Property distribution of drug-related chemical databases.
    Oprea TI
    J Comput Aided Mol Des; 2000 Mar; 14(3):251-64. PubMed ID: 10756480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead-like, drug-like or "Pub-like": how different are they?
    Oprea TI; Allu TK; Fara DC; Rad RF; Ostopovici L; Bologa CG
    J Comput Aided Mol Des; 2007; 21(1-3):113-9. PubMed ID: 17333482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current trends in lead discovery: are we looking for the appropriate properties?
    Oprea TI
    Mol Divers; 2002; 5(4):199-208. PubMed ID: 12549672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of the computed molecular properties of compounds selected for clinical development.
    Blake JF
    Biotechniques; 2003 Jun; Suppl():16-20. PubMed ID: 12813900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.
    Wager TT; Hou X; Verhoest PR; Villalobos A
    ACS Chem Neurosci; 2010 Jun; 1(6):435-49. PubMed ID: 22778837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leadlikeness and structural diversity of synthetic screening libraries.
    Verheij HJ
    Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technically Extended MultiParameter Optimization (TEMPO): An Advanced Robust Scoring Scheme To Calculate Central Nervous System Druggability and Monitor Lead Optimization.
    Ghose AK; Ott GR; Hudkins RL
    ACS Chem Neurosci; 2017 Jan; 8(1):147-154. PubMed ID: 27741392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
    Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
    Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
    Kéri G; Székelyhidi Z; Bánhegyi P; Varga Z; Hegymegi-Barakonyi B; Szántai-Kis C; Hafenbradl D; Klebl B; Muller G; Ullrich A; Erös D; Horváth Z; Greff Z; Marosfalvi J; Pató J; Szabadkai I; Szilágyi I; Szegedi Z; Varga I; Wáczek F; Orfi L
    Assay Drug Dev Technol; 2005 Oct; 3(5):543-51. PubMed ID: 16305311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in lead discovery: are we looking for the appropriate properties?
    Oprea TI
    J Comput Aided Mol Des; 2002; 16(5-6):325-34. PubMed ID: 12489682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore modeling in drug discovery and development: an overview.
    Khedkar SA; Malde AK; Coutinho EC; Srivastava S
    Med Chem; 2007 Mar; 3(2):187-97. PubMed ID: 17348856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the chemogenomic knowledge space with annotated chemical libraries.
    Savchuk NP; Balakin KV; Tkachenko SE
    Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyond.
    Odi R; Bibi D; Wager T; Bialer M
    Epilepsia; 2020 Aug; 61(8):1543-1552. PubMed ID: 32614073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Design and Analysis of a Kinase-Focused Combinatorial Library Considering Diversity and Quality.
    Yang Y; Zhang Y; Hua Y; Chen X; Fan Y; Wang Y; Liang L; Deng C; Lu T; Chen Y; Liu H
    J Chem Inf Model; 2020 Jan; 60(1):92-107. PubMed ID: 31886658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemography: the art of navigating in chemical space.
    Oprea TI; Gottfries J
    J Comb Chem; 2001; 3(2):157-66. PubMed ID: 11300855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraction of pharmacophore information from high-throughput screens.
    Hopfinger AJ; Duca JS
    Curr Opin Biotechnol; 2000 Feb; 11(1):97-103. PubMed ID: 10679338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the diversity of a corporate database using chemical database clustering and analysis.
    Shemetulskis NE; Dunbar JB; Dunbar BW; Moreland DW; Humblet C
    J Comput Aided Mol Des; 1995 Oct; 9(5):407-16. PubMed ID: 8594158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.